pharmaceuticals

Welcome to the 'pharmaceuticals' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'pharmaceuticals'.

Are you an expert about 'pharmaceuticals'? Do you want to be the Technorati authority on 'pharmaceuticals'? You can write a description that will appear right here: Join Blogcritics!

Original Technorati articles tagged “pharmaceuticals”

• in Technorati Women
  Poison Control Centers Seeing Ever Greater Dangers in the Medicine Cabinet
  Poison control centers, although facing possible funding cuts, provide an essential service to the American public.
  by jenna3967 / on Nov 9, 2011
• in Politics
  High Health Insurance Premiums: The Lobbyist Attack
  Why are health insurance premiums so high?
  by rabedela / on Nov 5, 2010

Latest blogosphere posts tagged “pharmaceuticals”

 

• Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic

  
  Xconomy — Authority: 643
  Luke Timmerman Pfizer was where Pedro Lichtinger learned about pharmaceutical marketing from people who did some amazing things. For starters, New York-based Pfizer turned an old-school antifungal medicine into a $1.6 billion cash cow. Now as the CEO of San Diego-based Optimer Pharmaceuticals (NASDAQ: OPTR ) ...
  23 hours ago

• Valeant Pulls Offer to Buy ISTA Pharmaceuticals

  
  OTC Showcase - Small Cap Stock Research — Authority: 121
  As a result of what Valeant Pharmaceuticals International Inc. (NYSE:VRX, TSX:VRX) called “a lack of progress,” Valeant has withdrawn its offer to buy ISTA Pharmaceuticals Inc. (NASDAQ:ISTA) for $7.50 a share in cash. Valeant had been aggressive in its efforts to acquire California-based ISTA, increasing the ...
  23 hours ago

• Fear-Resistance: How Worried Should We Be about "Totally Drug-Resistant" Tuberculosis?

  
  Scientific American — Authority: 135
  A few weeks ago a clinic in Mumbai claimed to have identified a dozen patients with a strain of tuberculosis (TB) resistant to all known treatments. TB is a highly contagious lung infection that kills about 1.5 million people each year worldwide, according to the World Health Organization (WHO), so the development of ...
  1 day ago

• Drug companies join forces to combat deadliest tropical diseases

  
  top99news - breaking news from the world top newspapers — Authority: 164
  http://www.guardian.co.uk Drug companies join forces to combat deadliest tropical diseases Bill Gates gets pharmaceutical giants to promise drug giveaways and unprecedented pledge to share research on new antidotesThe heads of 13 of the world’s biggest drug companies, brought together by Bill Gates, one ...
  1 day ago

• Drug companies join forces to combat deadliest tropical diseases

  
  The Guardian - guardian.co.uk — Authority: 962
  Bill Gates gets pharmaceutical giants to promise drug giveaways and unprecedented pledge to share research on new antidotes The heads of 13 of the worlds biggest drug companies, brought together by Bill Gates, one of the worlds richest men, have agreed to donate more medicines and, unprecedentedly, to work together ...
  1 day ago

• Rohto Laboratories Recruitment

  
  LKITnews — Authority: 440
  Company Profile PT. ROHTO LABORATORIES INDONESIA is a multinational company which is one subsidiary of ROHTO Pharmaceuticals Co.., Ltd.., Based in Osaka, Japan and has more than 100 years old and listed on the Japan Stock Exchange. ROHTO Pharmaceuticals Co.., Ltd. through its subsidiary Co. rubs. Inc., Based in New ...
  2 days ago

• OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation

  
  Xconomy — Authority: 643
  Luke Timmerman Prostate cancer was once a backwater for innovation, but suddenly it’s become one of the most competitive battlegrounds in all of biotech. And one of the darkhorses in this race, Bothell, WA and Vancouver, BC-based OncoGenex Pharmaceuticals, is getting ready to show next week whether it has another ...
  4 days ago

• Why Biogen Idec Got Out of the Corporate VC Business

  
  Xconomy — Authority: 643
  Luke Timmerman Steve Holtzman got his first taste of corporate venture capital back in 1987, when he raised money from SR One, back when it was part of an old company known as Smith, Kline & French. The concept was unorthodox 25 years ago, yet over time, most every Big Pharma company has become an active ...
  4 days ago

• Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015

  
  Your Story — Authority: 489
  The global genetic testing market represents one of the leading applications of the molecular diagnostics industry, in which the use of next-generation sequencing (NGS) platforms is small as compared to other sectors, but it is likely to grow in future. As per a new report released by RNCOS, the market for NGS has ...
  5 days ago

• Affymax Prepares to Mount First Challenge to Amgen Anemia Drug Monopoly

  
  Xconomy — Authority: 643
  Luke Timmerman Affymax shocked the world when an FDA advisory committee recommended last month that its anemia drug was good enough to earn a spot on the U.S. market. Now the Palo Alto, CA-based company (NASDAQ: AFFY ) is making all sorts of moves behind the scenes that will determine how big a bite it will ...
  6 days ago

• Industry Insiders Predict Significant Changes in Multiple Sclerosis

  
  eReleases Press Release Headlines — Authority: 130
  According to a new report from Intellent, MS industry insiders are candid in predicting significant changes and growth as novel therapies enter the market and prices of current therapies are reduced CHICAGO, Jan. 24, 2012 — In a new report detailing the Multiple Sclerosis landscape, industry insiders are candid in ...
  1 week ago

• Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race

  
  Xconomy — Authority: 643
  Luke Timmerman Vertex Pharmaceuticals went from king of the hill in the treatment of hepatitis C to yesterday’s news in about six wild months. But while many on Wall Street say Vertex’s big drug will soon become obsolete, Vertex and its small partner in South San Francisco have quietly put themselves in ...
  1 week ago

• FDA Declines to Recommend Approval of Progesterone Vaginal Gel

  
  Toonari Post - A News Mash Up! — Authority: 440
  Columbia Laboratories and Watson Pharmaceuticals has confirmed that the Advisory Committee for Reproductive Health Drugs of the U.S. Food and Drug Administration (FDA) did not recommend approval of progesterone vaginal gel 8% for the reduction of risk of preterm birth in women with short uterine cervical length at the ...
  1 week ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 581
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  1 week ago

• PTSD, whistleblowing and chemical injury: There are some human experiences that others can’t really understand

  
  Beyond Meds — Authority: 119
  "There are some human experiences that others can’t really understand. I learned a bit about that half a life ago when I developed a painful back problem that never got better, even with surgery. I learned to not talk about it, because even well-meaning responses were alienating. People would recount their own back ...
  1 week ago

• Millennium, Looking to Fend Off Onyx, Eagerly Awaits FDA Word on New Velcade

  
  Xconomy — Authority: 643
  Luke Timmerman The drug that made Millennium into a biotech power is on the verge of getting a subtle but meaningful upgrade, just in time to help the company fend off a serious new competing therapy from South San Francisco-based Onyx Pharmaceuticals (NASDAQ: ONXX ). Cambridge, MA-based Millennium, the cancer ...
  1 week ago

• Clarus Ventures Looks to Steer Ship Through Less Predictable Biotech Seas

  
  Xconomy — Authority: 643
  Luke Timmerman It’s never been easy to make a buck in biotech venture capital, but there used to be more predictability and logic to it, according to Clarus Ventures’ Nick Galakatos . You’d invest a few million, or tens of millions, and push a new drug or device toward some scientific validation in a few ...
  1 week ago

• Hadassah Medical Center to Honor Local Artist Stephanie Levine at CELL-A-BRATE

  
  Your Story — Authority: 489
  Local artist Stephanie Levine and her mother, Maddie, will be honored at the Hadassah Medical Center’s 6th annual CELL-A-BRATE event on Saturday, January 28, 2012 in Baltimore, MD. Baltimore, MD, January 18, 2011 – Local artist Stephanie Levine and her mother, Maddie, will be honored at the Hadassah Medical ...
  1 week ago

• Frazier Looks to Build Biotechs For Sale, Lay Groundwork for First Post-Crisis Fund

  
  Xconomy — Authority: 643
  Luke Timmerman Alan Frazier has been on record for a long time saying that the traditional biotech venture model is broken , and in severe need of updating. He’s been working on a new strategy for the past seven years or so, but the approach is facing its biggest test ever as Frazier prepares to raise his first ...
  1 week ago

• This Company is Quickly Approaching the Patent Cliff

  
  Fool.com: The Motley Fool — Authority: 695
  Earnings exceed expectations, but worries about future sales mount.
  1 week ago

Comments about pharmaceuticals